Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...
With the community hailing the latest FDA-approved therapeutic with Novartis’ inhibitor of the alternative complement for PNH, which inhibitor will be the next to harness the complement system for the ...
Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...
In recent years, the complement system has been implicated in the pathophysiology and progression of many disorders, notably modulating inflammation and causing endothelial and organ damage 1. Acute ...
Abstract: Recent breakthroughs in reconfigurable intelligent surface (RIS) technology are reshaping next-generation wireless networks. In multi-RIS deployments, however, the received signal becomes a ...
The Opti-GAIN study from Complement Therapeutics is assessing the safety, tolerability, and preliminary efficacy in GA secondary to age-related macular degeneration (AMD) of CTx001. A first-in-human ...
We propose a filter-based VINS framework named SchurVINS, which guarantees both high accuracy by building a complete residual model and low computational complexity with Schur complement. Technically, ...
Macrophage phagocytosis is a major cytotoxic mechanism for therapeutic monoclonal antibodies (mAbs) that opsonize target cells. This antibody-dependent cellular phagocytosis (ADCP) can occur via the ...
Abstract: The rapid advancement of artificial-intelligence (Al) models has increased demand for high-precision and energy-efficient edge-Al chips. Floating-point (FP) support is essential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results